Bacterial Skin and Skin Structure Infection

• FDA approval · 2022-01-14
  FDA Approved: ORBACTIV — Supplemental Application (Melinta Therapeutics, LLC)

  The FDA approved a supplemental application for ORBACTIV (oritavancin) submitted by Melinta Therapeutics, LLC. This action updates the drug'…

• FDA approval · 2020-10-20
  FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)

  FDA approved a supplemental application for NUZYRA (omadacycline) submitted by Paratek Pharmaceuticals, Inc.